Author

Jonas Widder

Ollscoil na Gaillimhe – University of GalwayPrimary ORCID profile (0009-0005-5127-1710 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jonas WidderiD2 papers · University of Cologne

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Organism:human· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Filippo MartinelliiD· 1 shared Ines ThieleiD· 1 shared Luciana HannibaliD· 1 shared Mohammadreza Moghimi· 1 shared Tim HenseniD· 1 shared Ute SpiekerkoetteriD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Filippo MartinelliORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Elucidating a potential role of the infant gut microbiome on the bioavailability of L-tyrosine in phenylketonuria

Mohammadreza Moghimi, Filippo Martinelli, Jonas Widder, Tim Hensen, Luciana Hannibal, Ute Spiekerkoetter, Ines Thiele

The paper uses metabolic models to show that gut microbiome composition affects L-tyrosine availability in PKU, suggesting microbiome-targeted therapies.

bioRxiv · Oct 28, 2025 · PreprintSystems Biology